New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For KORS;NTWK;FOSL;AVP;BCS;ZIOP;VAL;LVLT;BYD;FB;QCOM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>
March 27, 2015
07:59 EDTLVLTLevel 3 volatility at low end of historic range as shares near six-year high
Subscribe for More Information
07:43 EDTFBFacebook price target raised to $98 from $89 at Barclays
Subscribe for More Information
06:08 EDTBCSJiayuan.com engages financial advisor, legal counsel to evaluate proposal letter
Jiayuan.com (DATE) announced that the special committee of the company's board has retained Barclays Bank (BCS) as its financial advisor and Davis Polk & Wardwell as its legal counsel in connection with its review and evaluation of the non-binding proposal letter, dated March 3, from Vast Profit Holdings that proposes a "going-private" transaction involving the acquisition of all of the outstanding ordinary shares of the company not already owned by Vast Profit. Paul Hastings LLP is acting as the company's legal counsel. The board cautions the company's shareholders and others considering trading in the company's securities that no decisions have been made by the Special Committee with respect to the company's response to the proposal and there can be no assurance that any definitive offer will be made, that any agreement will be executed or that this or any other transaction will be approved or consummated.
06:04 EDTFBFacebook to test drone this summer, WSJ says
Subscribe for More Information
March 26, 2015
16:01 EDTFBOptions Update; March 26, 2015
Subscribe for More Information
12:09 EDTFBBattleground stock: Analysts take opposite sides on Twitter
Twitter is emerging as a battleground stock with Rosenblatt today starting coverage with a Buy rating while Stifel kept its Sell rating highlighting what it sees as weak operating metrics. BULLISH TAKE: Twitter's revenue and earnings before interest taxes depreciation and amortization, or EBITDA margin are poised to rebound, Rosenblatt analyst Martin Pyykkonen wrote in a note to investors today. Among the company's positive catalysts are video clip ads which should prove popular with marketers, higher ad load rates, additional products that will increase user growth and the expansion of the company's sales force, which is reaching critical mass, the analyst believes. In general, Twitter can further monetize its ads starting this year by using targeted advertising, contended Pyykkonen. Twitter's ad targeting capabilities are at least as strong as those of Facebook (FB), added the analyst. Meanwhile, the company's recently acquired Periscope product, which enables live video streaming, could significantly affect Twitter's usage trends, he contended. BEARISH TAKE: Twitter's risk/reward ratio is negative, and the company's second quarter guidance may come in below consensus estimates, wrote Stifel analyst Scott Devitt. The company is facing a tough comparison in Q2, as its results in the quarter last year were boosted by the World Cup, Devitt stated. Moreover, Twitter has not significantly improved its core product, and the website may be less popular than investors expect, the analyst contended. Additionally, Facebook has launched a number of initiatives, including trending topics updates and a deal to distribute NFL clips, that compete with Twitter's core competencies, the analyst wrote. He kept a $38 price target and Sell rating on Twitter. PRICE ACTION: In mid-morning trading, Twitter rose 2% to $50.50.
11:20 EDTFBJudge says Zynga shareholders can pursue claims against company, Reuters says
Subscribe for More Information
09:36 EDTFBActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GILD TWTR FB KRFT BIDU TSLA CELG NFLX FCAU
08:26 EDTQCOMSemi stocks less likely to rebound now than in 4Q14, says Goldman
Subscribe for More Information
07:11 EDTVALGabelli to hold a conference
Subscribe for More Information
06:59 EDTFBFacebook video outpaces YouTube in recent metrics, BI says
Subscribe for More Information
06:41 EDTFBTwitter to outpace Yahoo in display ad revenue, WSJ says
Subscribe for More Information
06:13 EDTFBFacebook expands ad platform to include user data, Re/code says
Subscribe for More Information
March 25, 2015
18:16 EDTBCSSFX Entertainment CEO Sillerman engages Barclays Capital, Jefferies
Subscribe for More Information
16:00 EDTFBOptions Update; March 25, 2015
Subscribe for More Information
14:45 EDTFBFacebook testing new video autoplay feature, Re/code says
Subscribe for More Information
13:43 EDTFBzulily rises after teaming with Facebook on messenger platform
Shares of (ZU) moved higher after Facebook (FB) CEO Mark Zuckerberg discussed the social network's new Businesses on Messenger product at today's developer conference. The product's initial partners in the retail vertical are zulily and Everlane, Zuckerberg announced. Zendesk (ZEN) will power Facebook's new messenger product, the company announced in a press release. Shares of zulily are up 38c to $13.40 as Zuckerberg's keynote speech continues.
13:37 EDTFBZendesk announces messenger partnership with Facebook
Zendesk (ZEN) announced a partnership to power Facebook's (FB) new Businesses on Messenger product. "Through an integration of its Zopim chat product with Messenger, Zendesk is allowing businesses to provide scalable and responsive customer service to the more than 600 million people worldwide who use Messenger," the company said. Online retailers zulily (ZU) and Everlane are the first two companies using the integration to support their customers, Zendesk added.
13:33 EDTFBzulily jumps after Facebook says initial partner on messenger platform
Subscribe for More Information
11:01 EDTZIOPZiopharm May volatility elevated at 129
Ziopharm April call option implied volatility is at 123, May is at 129, July is at 106; compared to its 26-week average of 120 according to Track Data, suggesting large April price movement.
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use